GSA Capital Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
67,901
+45,365
+201% +$792K 0.06% 492
2026
Q1
$432K Sell
22,536
-8,648
-28% -$188K 0.03% 1009
2025
Q4
$685K Sell
31,184
-67,757
-68% -$1.22M 0.06% 609
2025
Q3
$1.2M Buy
+98,941
New +$1.34M 0.1% 291
2025
Q2
Sell
-130,595
Closed -$2.5M 2149
2025
Q1
$2.5M Buy
+130,595
New +$3.82M 0.23% 27
2024
Q3
Sell
-19,260
Closed -$776K 2011
2024
Q2
$776K Buy
19,260
+10,867
+129% +$453K 0.05% 685
2024
Q1
$297K Buy
+8,393
New +$225K 0.02% 1223
2022
Q4
Sell
-10,138
Closed -$485K 1890
2022
Q3
$485K Buy
10,138
+4,877
+93% +$267K 0.06% 589
2022
Q2
$311K Buy
5,261
+1,244
+31% +$102K 0.05% 800
2022
Q1
$467K Buy
+4,017
New +$469K 0.06% 584
2021
Q3
Sell
-2,092
Closed -$204K 1771
2021
Q2
$204K Buy
+2,092
New +$187K 0.02% 1176
2020
Q4
Sell
-2,061
Closed -$234K 1597
2020
Q3
$234K Buy
+2,061
New +$217K 0.04% 909
2019
Q3
Sell
-9,368
Closed -$604K 1710
2019
Q2
$604K Buy
9,368
+513
+6% +$33.1K 0.07% 547
2019
Q1
$562K Buy
+8,855
New +$465K 0.06% 626
2018
Q4
Sell
-15,118
Closed -$648K 1735
2018
Q3
$648K Buy
+15,118
New +$528K 0.04% 942

Other funds holding TNDM

GSA Capital Partners's TNDM Position: Q2 2026 in Review

GSA Capital Partners increased its Tandem Diabetes Care (TNDM) stake by 201% in Q2 2026, buying an estimated $792K and bringing the position to 67,901 shares worth $1.02M. The position accounts for 0.06% of the portfolio, ranked #492.

GSA Capital Partners first reported a position in TNDM in Q3 2018 and has held it in 15 quarters since. The position peaked at $2.5M in Q1 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • GSA Capital Partners held 67,901 shares of Tandem Diabetes Care worth $1.02M as of Q2 2026.
  • GSA Capital Partners bought 45,365 Tandem Diabetes Care shares in Q2 2026, an estimated $792K.
  • Tandem Diabetes Care made up 0.06% of GSA Capital Partners's portfolio in Q2 2026, its #492 holding.
  • GSA Capital Partners first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 15 quarters since.
  • GSA Capital Partners's Tandem Diabetes Care position peaked at $2.5M in Q1 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.